SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

We reported the clinical characteristics and liver pathological manifestations of COVID-19 patients with elevated liver enzymes. Our findings suggested SARS-CoV-2 infection in liver is a crucial cause of hepatic impairment in COVID-19 patients
Source: Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research